notes 1 - 1 of 1:
2008-07-09
Xenoport rises as analysts tout drug candidate - Forbes.com
Shares of Xenoport Inc. rose Wednesday after analysts said the company's lead drug candidate will likely be approved by the Food and Drug Administration and has blockbuster sales potential in neurological and pain disorders.




